Thursday, November 12, 2026

USD/EUR Is 3% Down In The Last 21 Sessions

ViaNews Editorial Team

February 3, 2023

USD/EUR Is 3% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 3.5% for the last 21 sessions. At 05:10 EST on Friday, 3 February, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 5.161% up from its 52-week low and 12.717% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.15%, a negative 0.09%, and a positive 0.52%, respectively.

USD/EUR's highest amplitude of average volatility was 0.19% (last week), 0.42% (last month), and 0.52% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Eur/usd price analysis: rising wedge propels bearish interest ahead of FOMC. According to FXStreet on Wednesday, 1 February, "It's worth noting that the RSI (14) pullback from overbought territory joins the bearish MACD signals to challenge the EUR/USD bulls.", "On the flip side, the 21-day EMA level of 1.0800 restricts immediate EUR/USD moves ahead of highlighting the stated wedge's lower line, close to 1.0775 at the latest."
  • Eur/usd forex signal: prepares for a bearish breakout - 01 February 2023. According to DailyForex on Wednesday, 1 February, "The EUR/USD will react to the preliminary European inflation data scheduled for Wednesday morning. ", "The EUR/USD price moved sideways on Wednesday with the focus now being the upcoming Fed decision. "
  • Eur/usd adds to recent gains and retargets 1.0900, FOMC eyed. According to FXStreet on Wednesday, 1 February, "The European currency keeps the optimism unchanged for the second session in a row and lifts EUR/USD back to the vicinity of the 1.0900 hurdle on Wednesday.", "The acute comeback allows EUR/USD to flirt once again with the key 1.0900 neighbourhood ahead of the FOMC gathering and the ECB event."
  • Eur/usd: 1.08 support could be heavily tested after the fed announcement – ING. According to FXStreet on Wednesday, 1 February, "We think that EUR/USD will ultimately come out weaker from these two days of central bank activity.", "An exploration of the 1.0700-1.0750 range is surely possible in the near term, even though the longer-term outlook keeps pointing to a Dollar decline and EUR/USD strength."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com